AVXL logo

Anavex Life Sciences (AVXL)

Profile

Full Name

Anavex Life Sciences Corp.

Ticker Symbol

AVXL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 2, 2006

Indexes

Not included

Website

http://www.anavex.com

Employees

42

Key Details

Price

$8.95(+1.24%)

Market cap

$761.32M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.52(+13.33% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$8.95
AVXL price is $8.95

30-Day Relative Volume

0.30
AVXL 30-day relative volume is 0.30

Price Performance

Price Today change

+1.24%
AVXL price is up +1.24% today

Price YTD change

-16.67%
AVXL price is down -16.67% since January 1st

Price 1-year change

+119.9%
AVXL price is up +119.9% year-on-year

Price 3-year change

-19.37%
AVXL price is down -19.37% over the past 3 years

Price Range

Price All-time high

$31.50
AVXL price is currently -71.59% below its historical high of $31.50

Price 3-year low

$3.25
AVXL price is currently +175.38% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$761.32M
AVXL market capitalization is $761.32 million

Market cap 3-year change

-11.11%
AVXL market capitalization is down -11.11% over the past 3 years

Market cap All-time high

$2.09B
AVXL market capitalization is currently -63.57% below its historical high of $2.09 billion

Market cap sector rank

73.93%
AVXL market capitalization is higher than 73.93% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.73%
AVXL shares outstanding is up +1.73% year-on-year

Shares Outstanding 3-Year Change

+10.24%
AVXL shares outstanding is up +10.24% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.33
AVXL beta is 1.33

200-day SMA

$7.67
AVXL price is currently +16.63% above its 200-day simple moving average

50-day SMA

$8.73
AVXL price is currently +2.47% above its 50-day simple moving average

RSI

51.90
AVXL 14-day relative strength index is 51.90

Volume

0.30
AVXL 30-day relative volume is 0.30

ATR

$0.63
AVXL average true range is $0.63

10-day Historical Volatility

96.32%
AVXL 10-day historical volatility is 96.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
AVXL annual revenue value is unknown

Revenue Analysts estimate

-
AVXL annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
AVXL annual revenue 1-year change is unknown

Revenue Sector rank

-
AVXL annual revenue is unknown

EPS

EPS

-$0.52
AVXL annual earnings per share is -$0.52

EPS Analysts estimate

-$0.65
AVXL annual earnings per share is currently -20.00% lower than the consensus analysts' forecast

EPS 1-year change

+13.33%
AVXL annual earnings per share is up +13.33% year-on-year

EPS Sector rank

67.93%
AVXL annual earnings per share is higher than 67.93% of companies in Healthcare sector

Profit

Gross profit

-
AVXL annual gross profit value is unknown

Gross margin

-
AVXL annual gross profit margin value is unknown

Operating profit

-$52.80M
AVXL annual operating income is -$52.80 million

Operating margin

-
AVXL annual operating profit margin value is unknown

Net income

-$43.00M
AVXL annual net profit is -$43.00 million

Net margin

-
AVXL annual net profit margin value is unknown

Expenses

Total expenses

$52.80M
AVXL annual total expenses is $52.80 million

Operating expenses

$52.80M
AVXL annual total operating expenses is $52.80 million

Cost of goods sold

-
AVXL annual cost of goods sold value is unknown

Selling, general & administrative expenses

$11.04M
AVXL annual SGA is $11.04 million

Depreciation and amortization

-
AVXL annual depreciation & amortization value is unknown

Interest expense

$0.00
AVXL annual interest expense is $0.00

Income tax

$0.00
AVXL annual income tax is $0.00

EBIT & EBITDA

EBIT

-$43.00M
AVXL annual earnings before interest & taxes is -$43.00 million

EBITDA

-$43.00M
AVXL annual EBITDA is -$43.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$135.57M
AVXL annual total assets is $135.57 million

Non current assets

$0.00
AVXL annual long term assets is $0.00

Current assets

$135.57M
AVXL annual total current assets is $135.57 million

Cash and cash equivalents

$132.19M
AVXL annual cash & cash equivalents is $132.19 million

Accounts receivable

-
AVXL annual accounts receivable value is unknown

Inventory

-
AVXL annual inventory value is unknown

Liabilities

Total liabilities

$15.30M
AVXL annual total liabilities is $15.30 million

Long term liabilities

$0.00
AVXL annual total long term liabilities is $0.00

Current liabilities

$15.30M
AVXL annual total current liabilities is $15.30 million

Accounts payable

$9.63M
AVXL annual accounts payable is $9.63 million

Debt

Total debt

$0.00
AVXL annual total debt is $0.00

Total debt 1-year change

0%
AVXL {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
AVXL annual long term debt value is unknown

Short term debt

-
AVXL annual short term debt value is unknown

Equity & Capital

Shareholders equity

$120.26M
AVXL annual stockholders equity is $120.26 million

Book value

$120.26M
AVXL annual book value is $120.26 million

Retained earnings

-$336.07M
AVXL annual retained earnings is -$336.07 million

Working capital

$120.26M
AVXL annual working capital is $120.26 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$30.81M
AVXL annual cash flow from operations is -$30.81 million

Cash from operations 1-year change

-10.89%
AVXL annual cash flow from operations is down -10.89% year-on-year

Cash from investing

-
AVXL annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
AVXL annual cash flow from investing activities 1-year change is unknown

Cash from financing

$11.97M
AVXL annual cash flow from financing activities is $11.97 million

Cash from financing 1-year change

-59.61%
AVXL annual cash flow from financing activities is down -59.61% year-on-year

CAPEX

CAPEX

-
AVXL annual capital expenditures value is unknown

CAPEX 1-year change

-
AVXL annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$30.81M
AVXL annual free cash flow is -$30.81 million

Free cash flow 1-year change

-10.89%
AVXL annual free cash flow is down -10.89% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
AVXL annual gross profit margin value is unknown

Operating margin

-
AVXL annual operating profit margin value is unknown

Net margin

-
AVXL annual net profit margin value is unknown

ROA & ROE

ROA

-31.72%
AVXL annual return on assets is -31.72%

ROE

-35.76%
AVXL annual return on equity is -35.76%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AVXL price to earnings ratio value is unknown

PE ratio Sector rank

-
AVXL price to earnings ratio is unknown

PB Ratio

PB ratio

6.86
AVXL price to book ratio is 6.86

PB ratio Sector rank

88.55%
AVXL price to book ratio is higher than 88.55% of companies in Healthcare sector

PS Ratio

PS ratio

-
AVXL price to sales ratio value is unknown

PS ratio Sector rank

-
AVXL price to sales ratio is unknown

Enterprise value

Enterprise value

$640.55M
AVXL enterprise value is $640.55 million

Enterprise value Sector rank

72.09%
AVXL enterprise value is higher than 72.09% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-13.33
AVXL EV/EBITDA is -13.33

EV/EBITDA Sector rank

8.78%
AVXL EV/EBITDA is higher than 8.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.86
AVXL annual current ratio is 8.86

Quick ratio

-
AVXL annual quick ratio value is unknown

Leverage

Debt to equity

0.00
AVXL annual debt to equity ratio is 0.00

Interest coverage ratio

-
AVXL annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
AVXL piotroski f-score value is unknown

Altman Z-Score

-
AVXL altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 7, 25 HC Wainwright & Co.
Buy
Apr 7, 25 D. Boral Capital
Buy
Mar 31, 25 HC Wainwright & Co.
Buy
Feb 18, 25 HC Wainwright & Co.
Buy
Feb 12, 25 D. Boral Capital
Buy
Jan 28, 25 HC Wainwright & Co.
Buy
Jan 28, 25 D. Boral Capital
Buy
Jan 21, 25 HC Wainwright & Co.
Buy
Jan 15, 25 D. Boral Capital
Buy
Jan 13, 25 D. Boral Capital
Buy

Institutional Ownership

Similar stocks

SYRE logo
Spyre Therapeutics (SYRE)
PHVS logo
Pharvaris NV (PHVS)
NUTX logo
Nutex Health (NUTX)
NRIX logo
Nurix Therapeutics (NRIX)
VIR logo
Vir Biotechnology (VIR)
GYRE logo
Gyre Therapeutics (GYRE)
MYGN logo
Myriad Genetics (MYGN)
ZYME logo
Zymeworks (ZYME)
CVAC logo
CureVac NV (CVAC)
  • What is the ticker symbol for Anavex Life Sciences?
  • Does Anavex Life Sciences pay dividends?
  • What sector is Anavex Life Sciences in?
  • What industry is Anavex Life Sciences in?
  • What country is Anavex Life Sciences based in?
  • When did Anavex Life Sciences go public?
  • Is Anavex Life Sciences in the S&P 500?
  • Is Anavex Life Sciences in the NASDAQ 100?
  • Is Anavex Life Sciences in the Dow Jones?
  • When was Anavex Life Sciences's last earnings report?
  • When does Anavex Life Sciences report earnings?
  • Should I buy Anavex Life Sciences stock now?

What is the ticker symbol for Anavex Life Sciences?

The ticker symbol for Anavex Life Sciences is NASDAQ:AVXL

Does Anavex Life Sciences pay dividends?

No, Anavex Life Sciences does not pay dividends

What sector is Anavex Life Sciences in?

Anavex Life Sciences is in the Healthcare sector

What industry is Anavex Life Sciences in?

Anavex Life Sciences is in the Biotechnology industry

What country is Anavex Life Sciences based in?

Anavex Life Sciences is headquartered in United States

When did Anavex Life Sciences go public?

Anavex Life Sciences's initial public offering (IPO) was on August 2, 2006

Is Anavex Life Sciences in the S&P 500?

No, Anavex Life Sciences is not included in the S&P 500 index

Is Anavex Life Sciences in the NASDAQ 100?

No, Anavex Life Sciences is not included in the NASDAQ 100 index

Is Anavex Life Sciences in the Dow Jones?

No, Anavex Life Sciences is not included in the Dow Jones index

When was Anavex Life Sciences's last earnings report?

Anavex Life Sciences's most recent earnings report was on Feb 12, 2025

When does Anavex Life Sciences report earnings?

The next expected earnings date for Anavex Life Sciences is May 9, 2025

Should I buy Anavex Life Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page